Perimenopause Management

Introduction

Perimenopause requires comprehensive cardiovascular risk assessment and targeted symptom management with non-hormonal therapies as first-line treatment for most women, according to the American Heart Association 1

Comprehensive cardiovascular risk assessment is required for all women ages 40-75, including evaluation of lipid profile, blood pressure, weight/BMI, family history, smoking status, and diabetes/glucose tolerance, as recommended by the American College of Cardiology 1
Laboratory assessment, including FSH levels, estradiol levels, and TSH, can help diagnose perimenopause, with elevated FSH levels (>30 IU/L) suggesting perimenopause 1

Non-hormonal therapies, such as lifestyle modifications (temperature control, trigger avoidance, regular physical activity, and stress reduction techniques), are recommended as first-line treatment for managing symptoms like hot flashes, night sweats, and sleep disturbances 1
Pharmacologic options, including SSRIs/SNRIs (e.g., venlafaxine 37.5-75 mg/day or paroxetine 7.5-25 mg/day) and anticonvulsants (e.g., gabapentin 300-900 mg/day), can be considered for severe symptoms, as suggested by the American College of Obstetricians and Gynecologists 2

Hormone therapy is not recommended as first-line treatment due to potential risks, but may be considered for severe symptoms affecting quality of life, with contraindications including history of breast cancer, active liver disease, uncontrolled hypertension, and history of venous thromboembolism, as stated by the American College of Physicians 3
Low-dose vaginal estrogen has minimal systemic absorption and can be considered for severe urogenital symptoms, but safety is not fully established after breast cancer, according to the American Society of Clinical Oncology 2

Cognitive behavioral therapy and SSRIs/SNRIs can be effective for managing mood and sleep issues, as recommended by the American Psychiatric Association 2
Regular follow-up, including annual cardiovascular risk assessment, breast and cervical cancer screening, and bone density assessment if indicated, is necessary to monitor symptoms and adjust treatment as needed, as suggested by the American College of Preventive Medicine 2

Misdiagnosing perimenopause as thyroid disorder, depression, or anxiety, and overlooking cardiovascular risk assessment during this critical window, can have significant consequences, as warned by the American Academy of Family Physicians 4